Heinemeyer G, Nau H, Hildebrandt A G, Roots I
Biochem Pharmacol. 1985 Jan 1;34(1):133-9. doi: 10.1016/0006-2952(85)90111-x.
The influence of phenobarbital, clofibrate, 3-methylcholanthrene and beta-naphthoflavone on omega- and beta-oxidation as well as on glucuronidation of valproic acid (n-dipropylacetic acid) was evaluated in male Sprague-Dawley rats by determination of urinary excretion of its metabolites by GC-MS after administration of 100 mg/kg. In controls 12% of the dose was excreted within 24 hours, primarily as glucuronides; metabolites formed by oxidation amounted to about 4%. Phenobarbital treatment led to stimulation of 4-hydroxyvalproic acid [(omega-1)-oxidation], 5-hydroxyvalproic acid and n-propylglutaric acid (omega-oxidation) excretion. Clofibrate enhanced the excretion of 4-hydroxyvalproic acid and 3-keto-valproic acid, a product of peroxisomal beta-oxidation. beta-Naphthoflavone slightly increased the excretion of 5-hydroxyvalproic acid. The most specific effect was found for 3-methylcholanthrene, which was effective in stimulating the formation of 3-hydroxyvalproic acid which might be formed by (omega-2)-oxidation. The addition of fatty acids (olive oil in which 3-methylcholanthrene and beta-naphthoflavone were suspended) led to increased excretion of 3-keto-valproic, 4-hydroxyvalproic and n-propylglutaric acid. The excretion of 3-hydroxyvalproic acid was completely suppressed by olive oil. Such specific effects were not observed for glucuronidation of valproic acid and its metabolites, although stimulation was attained after phenobarbital, clofibrate and 3-methylcholanthrene treatment, because of instability of glucuronide conjugates. Stimulation of valproic acid metabolism was also shown by increased plasma clearance after treatment with phenobarbital. In contrast, clofibrate given once 1 hr before valproic acid inhibited excretion of valproic acid, possibly by competition during renal tubular secretion. Determination of valproic acid metabolites in urine provides a useful tool for evaluation of inducer specificity of short chain fatty acid metabolism and differentiation between microsomal and peroxisomal enzyme activity.
通过气相色谱-质谱联用仪(GC-MS)测定100mg/kg剂量丙戊酸(正二丙基乙酸)给药后雄性斯普拉格-道利大鼠尿液中代谢产物的排泄情况,评估苯巴比妥、氯贝丁酯、3-甲基胆蒽和β-萘黄酮对丙戊酸的ω-氧化和β-氧化以及葡萄糖醛酸化的影响。在对照组中,12%的剂量在24小时内排出,主要以葡萄糖醛酸苷形式排出;氧化形成的代谢产物约占4%。苯巴比妥治疗导致4-羟基丙戊酸[(ω-1)-氧化]、5-羟基丙戊酸和正丙基戊二酸(ω-氧化)排泄增加。氯贝丁酯增加了4-羟基丙戊酸和3-酮基丙戊酸(过氧化物酶体β-氧化产物)的排泄。β-萘黄酮略微增加了5-羟基丙戊酸的排泄。发现3-甲基胆蒽的作用最为特异,它能有效刺激3-羟基丙戊酸的形成,该产物可能由(ω-2)-氧化形成。添加脂肪酸(悬浮有3-甲基胆蒽和β-萘黄酮的橄榄油)导致3-酮基丙戊酸、4-羟基丙戊酸和正丙基戊二酸排泄增加。3-羟基丙戊酸的排泄被橄榄油完全抑制。尽管苯巴比妥、氯贝丁酯和3-甲基胆蒽治疗后由于葡萄糖醛酸苷结合物的不稳定性而实现了刺激,但丙戊酸及其代谢产物的葡萄糖醛酸化未观察到这种特异性作用。苯巴比妥治疗后血浆清除率增加也表明丙戊酸代谢受到刺激。相比之下,在丙戊酸给药前1小时给予一次氯贝丁酯会抑制丙戊酸的排泄,可能是由于肾小管分泌过程中的竞争。尿液中丙戊酸代谢产物的测定为评估短链脂肪酸代谢诱导剂的特异性以及区分微粒体和过氧化物酶体酶活性提供了一种有用的工具。